Filing Flows › Nu Skin Enterprises (NUS) › Guidance & outlook
Nu Skin Enterprises (NUS) guidance and outlook
Nu Skin Enterprises (NUS) gave its guidance on Nov 5, 2026: Revenue $310M–$340M for Q4 2026; EPS $0.05–$0.15 for Q4 2026. Nu Skin Enterprises' 10-Q filed Nov 6, 2026 makes 5 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | Q4 2026 | $310M–$340M | new |
| EPS | Q4 2026 | $0.05–$0.15 | new |
From the earnings release filed Nov 5, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 6, 2026
- We assessed the recoverability of the related asset group comparing the carrying value to the undiscounted cash flows expected to be generated.
- During the three months ended June 30, 2026, we determined that the continued decline in our stock price and corresponding market capitalization as well as the decline in our manufacturing reporting unit’s forecast were triggering events that required us to perform a quantitative impairment analysis.
- We estimate that capital expenditures for the uses listed above will total approximately $40–60 million for 2026.
- Except for $60.0 million of earnings in Mainland China that we designated as indefinitely reinvested during the second quarter of 2018, we currently plan to repatriate undistributed earnings from our non-U.S. operations as necessary, considering the cash needs of our non-U.S. operations and the cash needs of our U.S. operations for dividends, stock repurchases, capital investments, debt repayment and strategic…
- We currently believe that existing cash balances, future cash flows from operations and existing lines of credit will be adequate to fund our cash needs on both a short- and long-term basis.
Nu Skin Enterprises' latest quarter
Nu Skin Enterprises, Q3 2026: revenue $311M (-15% year over year), operating margin 1.6%, net loss $742K, operating cash flow −$8.1M. The chart follows the revenue to costs, profit and cash.
Questions
Did Nu Skin Enterprises raise or lower its guidance?
Nu Skin Enterprises (NUS) gave its guidance on Nov 5, 2026: Revenue $310M–$340M for Q4 2026; EPS $0.05–$0.15 for Q4 2026.
What does Nu Skin Enterprises expect?
We assessed the recoverability of the related asset group comparing the carrying value to the undiscounted cash flows expected to be generated. During the three months ended June 30, 2026, we determined that the continued decline in our stock price and corresponding market capitalization as well as the decline in our manufacturing reporting unit’s forecast were triggering events that required us to perform a quantitative impairment analysis. We estimate that capital expenditures for the uses listed above will total approximately $40–60 million for 2026.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.